About ALLTERUM THERAPEUTICS, INC.
Allterum Therapeutics is a biopharmaceutical company founded in 2018 by Fannin in Houston, TX, focusing on developing treatments for CD127 expressing cancers, particularly targeting the IL-7 pathway with a monoclonal antibody against CD127 (IL-7Rα).
Developing monoclonal antibodies for CD127 expressing cancersFocusing on relapsed/refractory hematologic malignancies and solid tumors with CD127 over-expressionLicensing and developing assets from academic institutions
Is this your company?
Claim ALLTERUM THERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ALLTERUM THERAPEUTICS, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.